FDA Readies Limits on Antibacterial Soap
The makers of antibacterial soaps and body washes will have to demonstrate that their products are safe, effective and prevent the spread of illness better than good old-fashioned soap and water, or they’ll have to conform to new rules, the Food and Drug Administration said Monday.
The FDA is focusing largely on triclosan (used in liquid soaps) and triclocarban (used in bar soaps, including many deodorant soaps).
If the products are not shown to be safe, effective and superior to soap and water in preventing disease spread, the FDA said manufacturers will be required to reformulate or re-label them as a condition of continued sale.
This article appeared in print on page 3 of edition of Hamodia.
To Read The Full Story
Are you already a subscriber?
Click "Sign In" to log in!
Become a Web Subscriber
Click “Subscribe” below to begin the process of becoming a new subscriber.
Become a Print + Web Subscriber
Click “Subscribe” below to begin the process of becoming a new subscriber.
Renew Print + Web Subscription
Click “Renew Subscription” below to begin the process of renewing your subscription.
